Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review Reeves ST; Turcasso NMSouth Med J 1997[Aug]; 90 (8): 769-74BACKGROUND: The use of nondepolarizing neuromuscular blocking drugs (NDNMBDs) via continuous infusion in the intensive care unit (ICU) is gaining in popularity. Several new NDNMBDs have been developed recently; these drugs vary in their elimination, metabolism, and half-lives. METHODS: A review of the recent English language literature was done, with those articles relevant to the ICU being incorporated into this paper. RESULTS: The six most frequently used NDNMBDs, consisting of atracurium, cisatracurium, doxacurlum, pancuronium, rocuronium, and vecuronium, were reviewed. The neuromuscular junction and impulse transmission, clinical monitoring, clinical pharmacology, the elimination and metabolism, the adverse reactions, and the drug interactions of these NDNMBDs are reviewed. CONCLUSIONS: The use of NDNMBDs is progressively increasing in ICUs. Proper understanding of normal neuromuscular physiology, clinical pharmacology, and drug interactions is essential to optimize patient care and to minimize the risk of adverse reactions.|*Critical Care[MESH]|Androstanols/therapeutic use[MESH]|Atracurium/analogs & derivatives/therapeutic use[MESH]|Drug Interactions[MESH]|Humans[MESH]|Infusions, Intravenous[MESH]|Isoquinolines/therapeutic use[MESH]|Neuromuscular Nondepolarizing Agents/adverse effects/pharmacology/*therapeutic use[MESH]|Pancuronium/therapeutic use[MESH]|Rocuronium[MESH]|Vecuronium Bromide/therapeutic use[MESH] |